search
Back to results

Treating Moderate Malnutrition in 6-24 Months Old Children (LUCOMA)

Primary Purpose

Moderate Acute Malnutrition

Status
Completed
Phase
Not Applicable
Locations
Burkina Faso
Study Type
Interventional
Intervention
Ready-to-Use Therapeutic Food (RUTF)
CBS++
CCC
Sponsored by
Institute of Tropical Medicine, Belgium
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Moderate Acute Malnutrition focused on measuring Malnutrition, Nutritional intervention, Behavioural intervention, Burkina Faso, Cluster randomize trial

Eligibility Criteria

6 Months - 24 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • living in the catchment area of one of the 18 health centres participating in this cluster randomized trial
  • 6-24 months of age
  • -3≤ weight for height z score <-2 without edema
  • No major clinical complications
  • Showing appetite

Exclusion Criteria:

  • Weight-for-Height Z-score <-3 and/or the presence of bilateral
  • Presence of bilateral pitting oedema
  • Not showing appetite

Sites / Locations

  • 18 Health Centres in Houndé District

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

Ready-to-Use Therapeutic Foood (RUSF)

CSB++

Children Centered Counseling (CCC)

Arm Description

Caretakers will receive weekly RUSF, 350g, and will be advised to feed it(50 g d-1 or 3 tablespoons/day) in one meal or on demand. These are pre-defined quantities. However, minimum quantities required for a timely (≤15 days) recovery from moderate malnutrition will be determined during the pilot phase. Besides supplementary food, parents will be provided with the usual nutrition counsels prevailing currently in the health services.Children will be home-visited once a week by assessors for anthropometry, 24-hours recall of dietary and breastfeeding intake, and morbidity signs. Feeding practices will be assessed, and the changes between baseline and intervention periods evaluated. Compliance will be evaluated by interviewing family members.

Caretakers will receive weekly CSB++ (450g) rations. Parents will be advised to feed the CSB++ (65g d-1 diluted in 370 g water) in one meal or on demand. These are pre-defined quantities. However, minimum quantities of CSB++ required for a timely (≤15 days) recovery from moderate malnutrition in the area will be determined during the pilot phase. Besides supplementary foods, parents will be provided with the usual nutrition counsels prevailing currently in the health services, i.e. to keep on breastfeeding, to increase diet diversity and to feed frequent snacks. Feeding practices will be also assessed, and the changes between baseline and intervention periods evaluated. Compliance will be evaluated by interviewing family members.

The counsellor will spend 1 hour daily (during the 3 first days and then weekly) within the household for identifying enhancing and blocking factors and adapt consequently the treatment strategies in agreement with the caretakers. As in the other study arms, children will be home-visited once a week by assessors for anthropometry, 24-hours recall of dietary and breastfeeding intake, and morbidity signs. Feeding practices will be also assessed in each arm, and the changes between baseline and intervention periods evaluated. Compliance will be evaluated by interviewing family members.There will be no dietary supplements intervention, outside normal practices in Burkina.

Outcomes

Primary Outcome Measures

Recovery rate
Weight-for-Height Z-score≥-1 SD
Morbidity rate
ARI, diarrhoea, anaemia and malaria incidence. Morbidity will be assessed every week by a locally pre-tested standardized questionnaire
Cost-effectiveness
The net differential costs and key outcomes for each intervention will be used to calculate the incremental cost-effectiveness ratios, i.e. the incremental costs divided by the incremental benefits. Specific cost-utility analysis will be performed to disentangle costs of a routine program including the intervention elements from those incurred from the research activities of the project.

Secondary Outcome Measures

Time to recovery
Relapse rate
Patients representing inclusion criteria within 3 months following discharge
Failure rate
Patients not gaining weight after 2 weeks or with a Weight-for-Height Z-score<-1 SD after 8 weeks
Default rate
Patient absent or refusing food during 2 consecutive weeks
Satisfaction of parents and acceptability
Survey to be conducted with households
Diet replacement & Intra-household dispatching of the food supplements
Assessment with households
Retinol & soluble serum transferrin receptors (Iron markers)
Retinol & soluble serum transferrin receptors (Iron markers)

Full Information

First Posted
April 29, 2010
Last Updated
November 21, 2011
Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
Institut de Recherche en Sciences de la Sante, Burkina Faso, Ministry of Health, Burkina Faso, University Ghent
search

1. Study Identification

Unique Protocol Identification Number
NCT01115647
Brief Title
Treating Moderate Malnutrition in 6-24 Months Old Children
Acronym
LUCOMA
Official Title
Treating Moderate Malnutrition in 6-24 Months Old Children: Acceptability, Efficacy and Cost-effectiveness of a Local Soy-based RUTF vs. Enhanced Corn Soy Blend vs. Child-centered Counselling
Study Type
Interventional

2. Study Status

Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
July 2010 (undefined)
Primary Completion Date
November 2011 (Actual)
Study Completion Date
November 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institute of Tropical Medicine, Belgium
Collaborators
Institut de Recherche en Sciences de la Sante, Burkina Faso, Ministry of Health, Burkina Faso, University Ghent

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Child malnutrition is intimately associated to poverty and may be due to sub-optimal feeding behaviours, food insecurity at household level, or a combination of both. Acute malnutrition is a major contributor to under-5 mortality and morbidity in developing countries. While clinical guidelines for severe acute malnutrition (SAM) have been available for a decade, research on the management of moderate acute malnutrition (MAM) has lagged behind. Nonetheless, MAM is much more incident than SAM, it increases mortality risk by itself and requires special nutritional treatment. This study is thus meant to address this major gap, by testing the relative feasibility, effectiveness and cost-effectiveness of three innovative strategies for treating children with MAM aged 6-24 months : a locally produced Ready-to-Use Therapeutic Food (RUTF), a corn/soy blended flour (CSB++)provided by the World Food Program, and a specific and context-appropriate child-centred counselling. The evaluation will be carried out as a cluster-randomized trial in the Houndé district, Burkina Faso, where 18 rural health centres will be randomly allocated to RUSF or CSB or CCC for treating MAM.
Detailed Description
Child malnutrition is intimately associated to poverty and may be due to sub-optimal feeding behaviours, food insecurity at household level, or a combination of both. Acute malnutrition is a major contributor to under-5 mortality and morbidity in low and middle income countries. Clinical guidelines for the management of severe acute malnutrition (SAM) have been available for a decade and have yielded excellent results. However, the corresponding research on the management of moderate acute malnutrition (MAM) has lagged behind, even if MAM is much more incident than SAM, increases mortality risk on its own and requires special nutritional treatment. Currently, the main management of MAM, in Burkina Faso as in most African countries, consists of giving nutritional advice to the caretakers, but mothers of MAM children are usually given the same general dietary advice as mothers of well-nourished children. A more efficient, child-centred approach must be developed, by adapting the counselling to the needs of the family, by developing a more child-centred approach, by providing operational recommendations for MAM children, and by providing an adequate follow-up post-treatment. This study is thus meant to address this major gap, by testing the relative feasibility, effectiveness and cost-effectiveness of three innovative strategies for treating children with MAM: a locally produced Ready-to-Use Therapeutic Food (RUTF), an enhanced corn/soy blended flour (CSB++)provided by the World Food Program, and a specific and context-appropriate child-centred counselling. The evaluation will be based on a cluster-randomized trial carried out in the Houndé district, Burkina Faso. Eighteen rural health centres and the population living in their catchment area will be randomly allocated to RUSF or CSB or CCC for treating MAM. Only children aged 6-24 months will be included as the risk of acute malnutrition is high and more amenable to interventions in this age range. Overall, 2088 children with MAM will participate. In each study arm, children will be home-visited once a week by assessors for anthropometry, 24-hours recall of dietary and breastfeeding intake, and morbidity signs. Feeding practices will be also assessed in each arm, and the changes between baseline and intervention periods evaluated. Compliance will be evaluated by interviewing family members.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Moderate Acute Malnutrition
Keywords
Malnutrition, Nutritional intervention, Behavioural intervention, Burkina Faso, Cluster randomize trial

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2088 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Ready-to-Use Therapeutic Foood (RUSF)
Arm Type
Experimental
Arm Description
Caretakers will receive weekly RUSF, 350g, and will be advised to feed it(50 g d-1 or 3 tablespoons/day) in one meal or on demand. These are pre-defined quantities. However, minimum quantities required for a timely (≤15 days) recovery from moderate malnutrition will be determined during the pilot phase. Besides supplementary food, parents will be provided with the usual nutrition counsels prevailing currently in the health services.Children will be home-visited once a week by assessors for anthropometry, 24-hours recall of dietary and breastfeeding intake, and morbidity signs. Feeding practices will be assessed, and the changes between baseline and intervention periods evaluated. Compliance will be evaluated by interviewing family members.
Arm Title
CSB++
Arm Type
Active Comparator
Arm Description
Caretakers will receive weekly CSB++ (450g) rations. Parents will be advised to feed the CSB++ (65g d-1 diluted in 370 g water) in one meal or on demand. These are pre-defined quantities. However, minimum quantities of CSB++ required for a timely (≤15 days) recovery from moderate malnutrition in the area will be determined during the pilot phase. Besides supplementary foods, parents will be provided with the usual nutrition counsels prevailing currently in the health services, i.e. to keep on breastfeeding, to increase diet diversity and to feed frequent snacks. Feeding practices will be also assessed, and the changes between baseline and intervention periods evaluated. Compliance will be evaluated by interviewing family members.
Arm Title
Children Centered Counseling (CCC)
Arm Type
Active Comparator
Arm Description
The counsellor will spend 1 hour daily (during the 3 first days and then weekly) within the household for identifying enhancing and blocking factors and adapt consequently the treatment strategies in agreement with the caretakers. As in the other study arms, children will be home-visited once a week by assessors for anthropometry, 24-hours recall of dietary and breastfeeding intake, and morbidity signs. Feeding practices will be also assessed in each arm, and the changes between baseline and intervention periods evaluated. Compliance will be evaluated by interviewing family members.There will be no dietary supplements intervention, outside normal practices in Burkina.
Intervention Type
Dietary Supplement
Intervention Name(s)
Ready-to-Use Therapeutic Food (RUTF)
Intervention Description
A Ready-to-Use Therapeutic Food (RUTF), locally produced in Burkina Faso. The RUSF will be nutritionally characterized by chemical analysis (macronutrients, amino acids, vitamins A, C, D, E, B12, thiamin, riboflavin, niacin, calcium, iron, zinc, copper, selenium) and will be analyzed for macronutrients and energy density. All analysis methods are either based on the Official Methods of Analysis of AOAC International or in-house validated analytical methods. The pilot production phase and Hazard Analysis of Critical Control Points (HACCP) risk inventory of the production process will be performed by a food technologist from the Department of Food safety and Food quality, Ghent University.
Intervention Type
Dietary Supplement
Intervention Name(s)
CBS++
Intervention Description
CSB is a low-cost combination of a cereal and a legume sometimes fortified with micronutrients. However, it presents shortcomings such as too many anti-nutrients, suboptimal micronutrient content, high bulk and viscosity. The World Food Program has recently proposed an enhanced CSB, named CSB++, which is prepared from heat treated maize and de-hulled soya beans, sugar, dried skim milk, refined soya bean oil, vitamins and minerals.
Intervention Type
Behavioral
Intervention Name(s)
CCC
Intervention Description
Child-Centred dietary Counselling (CCC). Although educational/behavioral interventions can be effective to improve child growth, there is little evidence of their effectiveness for MAM. Moreover, evidence from Africa is inexistent. Currently, the main management of MAM consists of giving nutritional advice to the caretakers, but mothers of MAM children are given the same general dietary advice as mothers of well-nourished children. A more efficient, child-centred approach is therefore proposed, by adapting the counselling to the needs of the family, developing a more child-centred approach, by providing operational recommendations for MAM children and providing an adequate follow-up post-treatment.
Primary Outcome Measure Information:
Title
Recovery rate
Description
Weight-for-Height Z-score≥-1 SD
Time Frame
One month (average)
Title
Morbidity rate
Description
ARI, diarrhoea, anaemia and malaria incidence. Morbidity will be assessed every week by a locally pre-tested standardized questionnaire
Time Frame
One month (average)
Title
Cost-effectiveness
Description
The net differential costs and key outcomes for each intervention will be used to calculate the incremental cost-effectiveness ratios, i.e. the incremental costs divided by the incremental benefits. Specific cost-utility analysis will be performed to disentangle costs of a routine program including the intervention elements from those incurred from the research activities of the project.
Time Frame
Twelve months
Secondary Outcome Measure Information:
Title
Time to recovery
Time Frame
One month (average)
Title
Relapse rate
Description
Patients representing inclusion criteria within 3 months following discharge
Time Frame
Up to three months (average)
Title
Failure rate
Description
Patients not gaining weight after 2 weeks or with a Weight-for-Height Z-score<-1 SD after 8 weeks
Time Frame
8 weeks
Title
Default rate
Description
Patient absent or refusing food during 2 consecutive weeks
Time Frame
2 weeks
Title
Satisfaction of parents and acceptability
Description
Survey to be conducted with households
Time Frame
Three months (average)
Title
Diet replacement & Intra-household dispatching of the food supplements
Description
Assessment with households
Time Frame
Three months (average)
Title
Retinol & soluble serum transferrin receptors (Iron markers)
Description
Retinol & soluble serum transferrin receptors (Iron markers)
Time Frame
Three months (average)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
24 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: living in the catchment area of one of the 18 health centres participating in this cluster randomized trial 6-24 months of age -3≤ weight for height z score <-2 without edema No major clinical complications Showing appetite Exclusion Criteria: Weight-for-Height Z-score <-3 and/or the presence of bilateral Presence of bilateral pitting oedema Not showing appetite
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Laetitia Ouedraogo Nikiema, MD, MSc
Organizational Affiliation
IRSS, Burkina Faso
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Dominique Roberfroid, MD MSc MPhil
Organizational Affiliation
ITM
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Patrick Kolsteren, MD, PhD
Organizational Affiliation
ITM, Antwerpen
Official's Role
Study Chair
Facility Information:
Facility Name
18 Health Centres in Houndé District
City
Houndé
Country
Burkina Faso

12. IPD Sharing Statement

Citations:
PubMed Identifier
24808482
Citation
Nikiema L, Huybregts L, Kolsteren P, Lanou H, Tiendrebeogo S, Bouckaert K, Kouanda S, Sondo B, Roberfroid D. Treating moderate acute malnutrition in first-line health services: an effectiveness cluster-randomized trial in Burkina Faso. Am J Clin Nutr. 2014 Jul;100(1):241-9. doi: 10.3945/ajcn.113.072538. Epub 2014 May 7.
Results Reference
derived

Learn more about this trial

Treating Moderate Malnutrition in 6-24 Months Old Children

We'll reach out to this number within 24 hrs